InvestorsHub Logo
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

Re: NickAidenNY post# 253862

Friday, 01/11/2019 9:26:29 AM

Friday, January 11, 2019 9:26:29 AM

Post# of 403064
"What everyone is missing is the real connecting of the dots. It’s quite unfortunate IPIX is on the OTC. It has given a private company the ability to try and destroy their competitor with means of OTC tricks and some proxies. Do some DD, do some tech savvy snoops and you’ll be able to see why the negative interest exists here and why the “non shareholders” know so much about the science of two drugs looking for the same wide open market. It’s pretty simple."

I don't know if it's unfortunate(in managements mind) to be on the otc. The quote below by the cfo/ceo was made over 5 years ago.

"As such, we have shifted our development strategy with our anti-psoriasis drug, Prurisol, to forego the planned Proof-of-Concept trial overseas and have already begun preparing the regulatory paperwork for the Food and Drug Administration to initiate a larger-scale, Phase 2/3 multi-center trial. The adjustment will save us hundreds of thousands of dollars and months of time that will now be better served to position us to potentially have up to five clinical trials ongoing in 2014. This acquisition dovetails very nicely in our goals to continue to build shareholder value and uplist to a senior exchange in the near future."

ph 2/3 P trial- missed it that much
5 clinical trials in 2014- missed it that much
uplist to a senior exchange in the near future- missed by a mile. There's always tomorrow!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News